Washington: Scientists have found that a MRSA infection with a reduced susceptibility to the antibiotic drug vancomycin is linked to high mortality.A Henry Ford Hospital study has found that patients who contracted a MRSA infection with heteroresistance, called hVISA, stayed in the hospital longer, were more likely to have the infection return after 90 days, and were twice as likely to die from it after 90 days than patients who do not have hVISA.
Reyes and researchers then compared characteristics and outcomes of the 19 hVISA patients against 19 non-hVISA patients, eliminating such factors as age, source of infection and level of sickness.They found that six hVISA patients died within 30 days compared to three non-hVISA patients. Also, five hVISA patients saw their infection return after 90 days compared to zero for non-hVISA patients.The study also found that hVISA patients stayed on average four more days in the hospital than non-hVISA patients and were more likely to have received vancomycin in the past. The study was presented at the 50th annual Interscience Conference on Antimicrobial Agents and Chemotherapy in Boston. ANI
Ceasefire violation: Pak targets 2 BSF posts in J&K
DDA housing scheme cleared, over 27K flats on offer
Gujarat: Wife meets lost husband via WhatsApp
Jaipur: Air India flight makes emergency landing due to technical fault